Burning Rock Biotech (BNR) Short-term Investments (2019 - 2026)

Burning Rock Biotech's Short-term Investments history runs 8 years deep, the most recent figure standing at $395000.0 for Q1 2026.

• In Q1 2026, Short-term Investments rose 26.6% year-over-year to $395000.0; the TTM figure through Mar 2026 stood at $395000.0 (up 26.6% YoY), while the FY2025 annual figure was $386000.0, up 21.77% from the prior year.
• Short-term Investments for Q1 2026 stood at $395000.0, up from $380116.1 in the prior quarter.
• The five-year high for Short-term Investments was $2.8 million in Q4 2022, with the low at $8000.0 in Q1 2024.
• The 5-year median for Short-term Investments is $322006.0 (2024), against an average of $548655.3.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments sank 99.43% in 2024, then soared 3800.0% in 2025.
• Burning Rock Biotech's Short-term Investments stood at $2.8 million in 2022, then tumbled by 99.4% to $16666.5 in 2023, then soared by 1832.06% to $322006.0 in 2024, then climbed by 18.05% to $380116.1 in 2025, then gained by 3.92% to $395000.0 in 2026.
• Business Quant data shows BNR's Short-term Investments at $395000.0 in Q1 2026, $380116.1 in Q4 2025, and $419000.0 in Q3 2025.